4.7 Review

Concise Review: Paracrine Role of Stem Cells in Pituitary Tumors: A Focus on Adamantinomatous Craniopharyngioma

Journal

STEM CELLS
Volume 34, Issue 2, Pages 268-276

Publisher

WILEY
DOI: 10.1002/stem.2267

Keywords

Pituitary; Stem cells; Sox2; Tumors; WNT pathway

Funding

  1. Children with Cancer UK (CWCUK) [W1055]
  2. Great Ormond Street Hospital Children's Charity (GOSHCC)
  3. Medical Research Council (MRC) [164126]
  4. National Institute for Health Research Biomedical Research Centre at Great Ormond Street Hospital for Children NHS Foundation Trust
  5. University College London
  6. Children with Cancer UK [15-190] Funding Source: researchfish
  7. Great Ormond Street Hospital Childrens Charity [W1055] Funding Source: researchfish
  8. Medical Research Council [MR/M000125/1, MR/L016729/1] Funding Source: researchfish
  9. MRC [MR/M000125/1, MR/L016729/1] Funding Source: UKRI

Ask authors/readers for more resources

The existence of tissue-specific progenitor/stem cells in the adult pituitary gland of the mouse has been demonstrated recently using genetic tracing experiments. These cells have the capacity to differentiate into all of the different cell lineages of the anterior pituitary and self-propagate in vitro and can therefore contribute to normal homeostasis of the gland. In addition, they play a critical role in tumor formation, specifically in the etiology of human adamantinomatous craniopharyngioma, a clinically relevant tumor that is associated with mutations in CTNNB1 (gene encoding beta-catenin). Mouse studies have shown that only pituitary embryonic precursors or adult stem cells are able to generate tumors when targeted with oncogenic beta-catenin, suggesting that the cell context is critical for mutant beta-catenin to exert its oncogenic effect. Surprisingly, the bulk of the tumor cells are not derived from the mutant progenitor/stem cells, suggesting that tumors are induced in a paracrine manner. Therefore, the cell sustaining the mutation in beta-catenin and the cell-of-origin of the tumors are different. In this review, we will discuss the in vitro and in vivo evidence demonstrating the presence of stem cells in the adult pituitary and analyze the evidence showing a potential role of these stem cells in pituitary tumors.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Cell Biology

Editorial

Abigail S. Tucker, Cynthia L. Andoniadou

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)

Article Multidisciplinary Sciences

Conditional Dicer1 depletion using Chrnb4-Cre leads to cone cell death and impaired photopic vision

Eduardo Zabala Aldunate, Valentina Di Foggia, Fabiana Di Marco, Laura Abelleira Hervas, Joana Claudio Ribeiro, Daniel L. Holder, Aara Patel, Tommaso B. Jannini, Dorothy A. Thompson, Juan Pedro Martinez-Barbera, Rachael A. Pearson, Robin R. Ali, Jane C. Sowden

SCIENTIFIC REPORTS (2019)

Editorial Material Endocrinology & Metabolism

Novel medications inducing adrenal insufficiency

Stefan R. Bornstein, Tobias D. Bornstein, Cynthia L. Andoniadou

NATURE REVIEWS ENDOCRINOLOGY (2019)

Article Endocrinology & Metabolism

Biological Behaviour of Craniopharyngiomas

Juan Pedro Martinez-Barbera, Cynthia Lilian Andoniadou

NEUROENDOCRINOLOGY (2020)

Letter Clinical Neurology

CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma

J. R. Apps, C. Stache, J. M. Gonzalez-Meljem, A. Gutteridge, J. Chalker, T. S. Jacques, T. Forshew, A. Hoelsken, J. P. Martinez-Barbera

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2020)

Review Endocrinology & Metabolism

Cancer Stem Cells in Pheochromocytoma and Paraganglioma

Laura D. Scriba, Stefan R. Bornstein, Alice Santambrogio, Gregor Mueller, Angela Huebner, Julia Hauer, Andreas Schedl, Ben Wielockx, Graeme Eisenhofer, Cynthia L. Andoniadou, Charlotte Steenblock

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Cell Biology

Galactose-modified duocarmycin prodrugs as senolytics

Ana Guerrero, Romain Guiho, Nicolas Herranz, Anthony Uren, Dominic J. Withers, Juan Pedro Martinez-Barbera, Lutz F. Tietze, Jesus Gil

AGING CELL (2020)

Review Clinical Neurology

Cell senescence in neuropathology: A focus on neurodegeneration and tumours

Gabriela Carreno, Romain Guiho, Juan Pedro Martinez-Barbera

Summary: The study of cell senescence is rapidly growing, with senescent cells secreting biologically active products that can affect the cellular microenvironment, known as SASP, with both beneficial and detrimental effects on tissue homeostasis. The use of senolytic drugs to eliminate senescent cells has shown promise in improving age-related diseases, and clearance of senescent cells may also improve neurodegenerative diseases and cancer.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2021)

Review Medicine, General & Internal

Hypothalamic syndrome

Hermann L. Mueller, Maithe Tauber, Elizabeth A. Lawson, Jale Oezyurt, Brigitte Bison, Juan-Pedro Martinez-Barbera, Stephanie Puget, Thomas E. Merchant, Hanneke M. van Santen

Summary: Hypothalamic syndrome is a rare disorder caused by injury to the hypothalamus from various diseases or their treatment. This Primer provides an overview of the epidemiology, pathophysiology, diagnosis and management of the syndrome, as well as the challenges in preventing hypothalamic injury and treating its sequelae.

NATURE REVIEWS DISEASE PRIMERS (2022)

Article Oncology

BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma

Florian Selt, Romain Sigaud, Gintvile Valinciute, Philipp Sievers, Julia Zaman, Clara Alco, Simone Schmid, Heike Peterziel, Jessica W. Tsai, Romain Guiho, Juan Pedro Martinez-Barbera, Stefan Pusch, Jing Deng, Yifan Zhai, Cornelis M. van Tilburg, Martin U. Schuhman, Ahmed E. L. Damaty, Pratiti Bandopadhayay, Christel Herold-Mende, Andreas von Deimling, Stefan M. Pfister, Joan Montero, David Capper, Ina Oehme, Felix Sahm, David T. W. Jones, Olaf Witt, Till Milde

Summary: Our study demonstrates that BCL-XL is critical for the survival of senescent PA tumor cells and provides evidence for the use of clinically available BCL-XL-dependent senolytic agents.

NEURO-ONCOLOGY (2023)

Review Endocrinology & Metabolism

Contemporary Biological Insights and Clinical Management of Craniopharyngioma

John Richard Apps, Hermann Lothar Muller, Todd Cameron Hankinson, Torunn Ingrid Yock, Juan Pedro Martinez-Barbera

Summary: Craniopharyngiomas are aggressive tumors that tend to recur after therapy. They are divided into two types based on histology and molecular features. Patients often experience symptoms related to the tumor location, such as increased intracranial pressure, endocrine deficiencies, and visual defects. Treatment options are diverse but mostly noncurative, including surgery and radiotherapy. Targeted therapies have been used in recent years, and clinical trials are ongoing. For patients at risk of hypothalamic syndrome, treatment strategies that spare the hypothalamus are recommended.

ENDOCRINE REVIEWS (2023)

Editorial Material Oncology

A promising future for hypothalamic dysfunction in craniopharyngioma

John Richard Apps, Juan Pedro Martinez-Barbera

NEURO-ONCOLOGY (2023)

Article Multidisciplinary Sciences

An expression and function analysis of the CXCR4/SDF-1 signalling axis during pituitary gland development

Jose Mario Gonzalez-Meljem, Sarah Ivins, Cynthia Lilian Andoniadou, Paul Le Tissier, Peter Scambler, Juan Pedro Martinez-Barbera

Summary: The role of the chemokine SDF-1 and its receptor CXCR4 in pituitary gland development was investigated. The expression patterns of CXCR4, SDF-1, and CXCR7 were characterized, and it was found that SDF-1 is expressed in progenitor-rich regions of the pituitary gland. Conditional deletion of CXCR4 in embryonic pituitary progenitors did not lead to observable defects, suggesting that CXCR4 expression in HESX1+ cells and their descendants is not essential for normal pituitary development in mice.

PLOS ONE (2023)

Review Biochemistry & Molecular Biology

Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis

Jose Mario Gonzalez-Meljem, Juan Pedro Martinez-Barbera

Summary: Cellular senescence can prevent tumour development autonomously but also promote tumour growth non-autonomously by creating a permissive tumour microenvironment. In a specific pituitary tumour ACP, senescent cell clusters with SASP play a critical role in tumour initiation. Evidence suggests that paracrine signalling from senescent cells may underlie tumourigenesis in various tumour and cancer models.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Meeting Abstract Genetics & Heredity

The role of cellular senescence and its associated secretome in paediatric Adamantinomatous Craniopharyngioma (ACP)

Saba Manshaei, Scott Haston, Jesus Gil, Juan Pedro Martinez-Barbera

GENETICS RESEARCH (2019)

No Data Available